Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.

Gueler, Aysel; Moser, André; Calmy, Alexandra; More

AIDS ., Post Acceptance: November 7, 2016

Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population

Gueler, Aysel; Moser, André; Calmy, Alexandra; More

AIDS . 31(3):427-436, January 28, 2017.

Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern

Muri, Lukas; Gamell, Anna; Ntamatungiro, Alex J.; More

AIDS . 31(1):61-70, January 2, 2017.

Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy

Stuehler, Claudia; Bernardini, Claudia; Elzi, Luigia; More

AIDS . 30(12):1923-1933, July 31, 2016.

The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV

Kohler, Philipp; Schmidt, Axel J.; Cavassini, Matthias; More

AIDS . 29(18):2509-2515, November 28, 2015.

Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality

Glass, Tracy R.; Sterne, Jonathan A.C.; Schneider, Marie-Paule; More

AIDS . 29(16):2195-2200, October 23, 2015.

HIV resistance testing and detected drug resistance in Europe

Schultze, Anna; Phillips, Andrew N.; Paredes, Roger; More

AIDS . 29(11):1379-1389, July 17, 2015.

Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults

Marzolini, Catia; Sabin, Caroline; Raffi, François; More

AIDS . 29(2):193-200, January 14, 2015.

Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease

Borges, Álvaro H.; Lundgren, Jens D.; Ridolfo, Annalisa; More

AIDS . 28(17):2565-2571, November 13, 2014.

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

Young, Jim; Schäfer, Juliane; Fux, Christoph A.; More

AIDS . 26(5):567-575, March 13, 2012.

Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death

Kaufmann, Gilbert R; Elzi, Luigia; Weber, Rainer; More

AIDS . 25(4):441-451, February 20, 2011.

Virosomal influenza-vaccine induced immunity in HIV-infected individuals with high versus low CD4+ T-cell counts: clues towards a rational vaccination strategy

Fritz, Stefanie; Mossdorf, Erik; Durovic, Bojana; More

AIDS . 24(14):2287-2289, September 10, 2010.

Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons

Berger, Simona; Schad, Tanja; von Wyl, Viktor; More

AIDS . 22(6):767-775, March 30, 2008.

Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy

Polesel, Jerry; Clifford, Gary M; Rickenbach, Martin; More

AIDS . 22(2):301-306, January 11, 2008.

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study

Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; More

AIDS . 21(16):2201-2207, October 2007.

Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST

Raffi, François; Battegay, Manuel; Rusconi, Stefano; More

AIDS . 21(14):1977-1980, September 2007.

Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir

Karrer, Urs; Ledergerber, Bruno; Furrer, Hansjakob; More

AIDS . 19(17):1987-1994, November 18, 2005.

The Role of CFTR and SPINK-1 Mutations in Pancreatic Disorders in HIV-Positive Patients : a Case Control Study

Felley, Christian; Morris, Michael A; Wonkam, Ambroise; More

AIDS . 18(14):1971, September 24, 2004.

The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case–control study

Felley, Christian; Morris, Michael A; Wonkam, Ambroise; More

AIDS . 18(11):1521-1527, July 23, 2004.

Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival

Staehelin, Cornelia; Rickenbach, Martin; Low, Nicola; More

AIDS . 17(15):2237-2244, October 17, 2003.

Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy

Greub, Gilbert; Cozzi-Lepri, Alessandro; Ledergerber, Bruno; More

AIDS . 16(14):1967-1969, September 27, 2002.

Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients

Khanna, Nina; Klimkait, Thomas; Schiffer, Veronique; More

AIDS . 14(7):791-799, May 5, 2000.

Highly active antiretroviral therapy during early HIV infection reverses T‐cell activation and maturation abnormalities

Bisset, Leslie R.; Cone, Richard W.; Huber, Werner; More

AIDS . 12(16):2115-2123, November 12, 1998.